These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 9300978)

  • 1. Hepatic embolization through extrahepatic collateral pathways after hepatic arterial embolization for the hepatocellular carcinoma.
    Iwata Y; Endo J; Saito T; Iwata T; Matsuyama S; Tanaka Y; Otani Y; Tsukui S; Goto K; Ikeuchi S
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):177-83. PubMed ID: 9300978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rupture of hepatocellular carcinoma after transcatheter arterial embolization: an unusual case.
    Sakamoto Y; Kita Y; Takayama T; Kawauchi N; Minagawa M; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):453-6. PubMed ID: 10228840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous rupture of hepatocellular carcinoma supplied by the right renal capsular artery treated by transcatheter arterial embolization.
    Kodama Y; Shimizu T; Endo H; Hige S; Kamishima T; Holland GA; Miyamoto N; Miyasaka K
    Cardiovasc Intervent Radiol; 2002; 25(2):137-40. PubMed ID: 11901433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic perfusion index in evaluating treatment effect of transcatheter hepatic artery embolization in patients with hepatocellular carcinoma.
    Lin WY; Wang SJ; Yeh SH
    Neoplasma; 1995; 42(2):89-92. PubMed ID: 7617083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma: involvement of the internal mammary artery.
    Nakai M; Sato M; Kawai N; Minamiguchi H; Masuda M; Tanihata H; Takeuchi T; Terada M; Kishi K
    Radiology; 2001 Apr; 219(1):147-52. PubMed ID: 11274549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of partial splenic embolization (PSE) in hepatocellular carcinomas showing a risk of gastrointestinal bleeding after transcatheter arterial embolization (TAE)].
    Ohmoto K; Yamamoto R; Yamamoto S; Ideguchi S; Saito I; Wada A; Takatori K; Ohumi T; Hino K; Hirano Y
    Gan No Rinsho; 1989 May; 35(6):690-5. PubMed ID: 2542638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of new hepaticoenteric collateral pathways after hepatic arterial skeletonization in preparation for yttrium-90 radioembolization.
    Abdelmaksoud MH; Hwang GL; Louie JD; Kothary N; Hofmann LV; Kuo WT; Hovsepian DM; Sze DY
    J Vasc Interv Radiol; 2010 Sep; 21(9):1385-95. PubMed ID: 20688531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intra-arterial digital subtraction angiography with conventional angiography after transcatheter arterial embolization for hepatic malignancy.
    Minakuchi K; Takada K; Manabe T; Kobayashi N; Nakamura K; Onoyama Y
    Radiat Med; 1989; 7(5):247-51. PubMed ID: 2560838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Sueyoshi E; Hayashida T; Sakamoto I; Uetani M
    AJR Am J Roentgenol; 2010 Jul; 195(1):245-51. PubMed ID: 20566824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrahepatic arterial blood supply of hepatocellular carcinoma and interventional treatment].
    Li C; Guo Y; Tian G; Shi Z; Liu D; Zeng H; Jiang W; Li H; Zhou C
    Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):163-6. PubMed ID: 12015039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization.
    Kim HC; Chung JW; Lee W; Jae HJ; Park JH
    Radiographics; 2005 Oct; 25 Suppl 1():S25-39. PubMed ID: 16227494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic changes after transcatheter arterial embolization of hepatocellular carcinomas.
    Taourel P; Dauzat M; Lafortune M; Pradel J; Rossi M; Bruel JM
    Radiology; 1994 Apr; 191(1):189-92. PubMed ID: 8134569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrahepatic collaterals and liver damage in embolotherapy for ruptured hepatic artery pseudoaneurysm following hepatobiliary pancreatic surgery.
    Tajima Y; Kuroki T; Tsutsumi R; Sakamoto I; Uetani M; Kanematsu T
    World J Gastroenterol; 2007 Jan; 13(3):408-13. PubMed ID: 17230610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy.
    Okazaki M; Yamasaki S; Ono H; Higashihara H; Koganemaru F; Kimura S; Kuroda Y; Sato S; Ryu K; Ohtsubo T
    Hepatogastroenterology; 1993 Aug; 40(4):320-3. PubMed ID: 8406299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrahepatic Collateral Artery Extravasation in Patients with Ruptured Hepatocellular Carcinoma.
    Nishiyama T; Kamo M; Horiuchi S; Okura M; Nakano K; Ikeya T; Ishii N; Fujita Y; Kurihara Y
    J Vasc Interv Radiol; 2018 Apr; 29(4):564-567. PubMed ID: 29579463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations].
    Nakamura H; Kawata S; Takamura M; Osuga K; Murakami T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful experience in transcatheter arterial embolization (TAE) after visualizing extravasation due to rupture of hepatocellular carcinoma (HCC)].
    Kitsuki H; Okazaki M
    Rinsho Hoshasen; 1988 Jun; 33(6):727-30. PubMed ID: 2851064
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of hepatocellular carcinoma fed by internal thoracic artery.
    Nakai M; Sato M; Kawai N; Minamiguchi H; Masuda M; Tanihata H; Takeuchi T; Terada M; Horihata K
    Cardiovasc Intervent Radiol; 2000 Jan; 23(1):83A. PubMed ID: 10656918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.